Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Intermediate-Risk Lymphocyte-Predominant Hodgkin Lymphoma: AHOD0031: A Report from the Children's Oncology Group

Lianna J. Marks, MD, Qinglin Pei, PhD, Allen Buxton, MS, Burton Appel, MD, Kara M. Kelly, MD, Cindy L. Schwartz, MD MPH, Debra L. Friedman, MD MS

Blood (2016) 128 (22): 1814.

https://doi.org/10.1182/blood.V128.22.1814.1814

Published: 2016

Journal Articles

Subsequent Malignant Neoplasms Among Children and Adolescents with Hodgkin Lymphoma Treated with Response-Adapted Therapy: A Report from the Children's Oncology Group Study AHOD0031

Lisa Giulino-Roth, MD, Qinglin Pei, PhD, Allen Buxton, MS, Suzanne Wolden, MD, Louis S. Constine, MD, Kara M. Kelly, MD, Cindy L. Schwartz, MD MPH, Debra L. Friedman, MD MS

Blood (2016) 128 (22): 924.

https://doi.org/10.1182/blood.V128.22.924.924

Published: 2016

Journal Articles

Prediction of Primary Treatment Outcome Using Gene Expression Profiling of Pre-Treatment Biopsies Obtained from Childhood and Adolescent Hodgkin Lymphoma Patients

Anja Mottok, MD, Rebecca Lea Johnston, Fong Chun Chan, MSc, David W Scott, MBChB, PhD, Debra L. Friedman, MD MS, Cindy Schwartz, MD, Kara M. Kelly, MD, Terzah M. Horton, MD PhD, Christian Steidl, MD

Blood (2015) 126 (23): 175.

https://doi.org/10.1182/blood.V126.23.175.175

Published: 2015

Journal Articles

An Adjustable Markov Model to Project Life Expectancy (LE) for Early Stage Favorable Risk Hodgkin Lymphoma Patients Treated with Contemporary Therapy

Michael J. Kelly, MD MPH, MS, Susan K Parsons, MDMRP, David C. Hodgson, MD, Joshua T Cohen, PhD, Jennifer M Yeh, MD PhD, Jeremy S. Abramson, MD, Debra L. Friedman, MD MS, Tara O Henderson, MDMPH, Peter W Johnson, MD, Stephen G Pauker, MD, John M. Raemaekers, MD PhD, Jane N. Winter, MD, Kara M. Kelly, MD, Ralph M. Meyer, MD, Sharon M Castellino, MD, Andrew M. Evens, DO, MSc

Blood (2015) 126 (23): 2635.

https://doi.org/10.1182/blood.V126.23.2635.2635

Published: 2015

Journal Articles

Outcomes in Adolescents and Young Adults (AYA) with Hodgkin Lymphoma (HL) Treated on US Cooperative Group Protocols: An Adult Intergroup (E2496) and Children's Oncology Group (COG AHOD0031) Comparative Analysis

Blood (2015) 126 (23): 2636.

https://doi.org/10.1182/blood.V126.23.2636.2636

Published: 2015

Journal Articles

18 f-FDG (FDG) PET Five-Point Visual and Quantitative SUV-Based Assessment and Prognosis in Pediatric Hodgkin Lymphoma (HL). A Preliminary Retrospective Analysis of Children's Oncology Group (COG) AHOD0031

Steve Y Cho, MD, Kathleen M McCarten, MD, Lu Chen, PhD, Debra L Friedman, MD, MS, Suzanne L Wolden, MD, Kathryn Karolczuk, Cindy L Schwartz, MD, MPH, Kara M Kelly, MD

Blood (2012) 120 (21): 1530.

https://doi.org/10.1182/blood.V120.21.1530.1530

Published: 2012

Journal Articles

The Childhood Hodgkin International Prognostic Score (CHIPS) for Predicting Event Free Survival in Pediatric and Adolescent Hodgkin Lymphoma,

Cindy Schwartz, MD, MPH, Lu Chen, PhD, Louis Constine, MD, Suzanne Wolden, Frank G Keller, MD, Kara M Kelly, MD, Debra l Friedman, MD, MS

Blood (2011) 118 (21): 3649.

https://doi.org/10.1182/blood.V118.21.3649.3649

Published: 2011

Journal Articles

AHOD0031: A Phase III Study of Dose-Intensive Therapy for Intermediate Risk Hodgkin Lymphoma: A Report From the Children's Oncology Group

Debra l Friedman, MD, MS, Suzanne Wolden, Louis Constine, MD, Lu Chen, PhD, Kathleen M McCarten, MD, T. J Fitzgerald, Pedro De Alarcon, MD, Allen R. Chen, MD, PhD, MHS, Robert Hutchison, MD, Peter Ehrlich, Nathan L. Kobrinsky, MD, FRCP, Meghan Higman, Shirley Hogan, Lorna Roll, Tanya Trippett, Cindy Schwartz, MD

Blood (2010) 116 (21): 766.

https://doi.org/10.1182/blood.V116.21.766.766

Published: 2010

Journal Articles

High Prevalence of Metabolic Syndrome Traits in Children with Acute Lymphoblastic Leukemia Entering Maintenance Therapy.

Adam J. Esbenshade, MD, Tatsuki Koyama, PhD, Jill H. Simmons, MD, James A. Whitlock, MD, Debra L. Friedman, MD, MS

Blood (2009) 114 (22): 4114.

https://doi.org/10.1182/blood.V114.22.4114.4114

Published: 2009

Journal Articles

Population-Based Analysis of Late Cardiovascular Morbidity and Hospitalizations After Hematopoietic Cell Transplantation.

Eric J Chow, MD, MPH, K. Scott Baker, MD, MS, Debra L. Friedman, MD, MS, Kara Cushing-Haugen, MS, Mary E.D. Flowers, MD, Beth A Mueller, DrPH, Stephanie J. Lee, MD, MPH

Blood (2009) 114 (22): 517.

https://doi.org/10.1182/blood.V114.22.517.517

Published: 2009

Journal Articles

Prevalence of Metabolic Syndrome among Childhood Leukemia Survivors Treated with and without Hematopoietic Cell Transplantation

Eric J Chow, MD, MPH, Jean E Sanders, MD, Christian Roth, MD, Paul A Hoffmeister, MPH, Debra L Friedman, MD, MS

Blood (2008) 112 (11): 455.

https://doi.org/10.1182/blood.V112.11.455.455

Published: 2008

Journal Articles

Risk Factors for Second Malignancies after Transplantation Differ between Allogeneic and Autologous Transplantation.

Debra L. Friedman, MD, MS, Wendy Leisenring, PhD, Mary E. Flowers, MD, Leona Holmberg, MD, PhD, Jeffrey Schwartz, PhD, H. Joachim Deeg, MD

Blood (2005) 106 (11): 1121.

https://doi.org/10.1182/blood.V106.11.1121.1121

Published: 2005

Journal Articles

Is the Risk of Breast Cancer Increased after Hematopoietic Cell Transplantation?.

Debra L. Friedman, MD, MS, Wendy Leisenring, ScD, Jeffrey Schwartz, PhD, H. Joachim Deeg, MD

Blood (2004) 104 (11): 55.

https://doi.org/10.1182/blood.V104.11.55.55

Published: 2004

NARROW

Intermediate-Risk Lymphocyte-Predominant Hodgkin Lymphoma: AHOD0031: A Report from the Children's Oncology Group

Subsequent Malignant Neoplasms Among Children and Adolescents with Hodgkin Lymphoma Treated with Response-Adapted Therapy: A Report from the Children's Oncology Group Study AHOD0031

Prediction of Primary Treatment Outcome Using Gene Expression Profiling of Pre-Treatment Biopsies Obtained from Childhood and Adolescent Hodgkin Lymphoma Patients

An Adjustable Markov Model to Project Life Expectancy (LE) for Early Stage Favorable Risk Hodgkin Lymphoma Patients Treated with Contemporary Therapy

Outcomes in Adolescents and Young Adults (AYA) with Hodgkin Lymphoma (HL) Treated on US Cooperative Group Protocols: An Adult Intergroup (E2496) and Children's Oncology Group (COG AHOD0031) Comparative Analysis

18 f-FDG (FDG) PET Five-Point Visual and Quantitative SUV-Based Assessment and Prognosis in Pediatric Hodgkin Lymphoma (HL). A Preliminary Retrospective Analysis of Children's Oncology Group (COG) AHOD0031

The Childhood Hodgkin International Prognostic Score (CHIPS) for Predicting Event Free Survival in Pediatric and Adolescent Hodgkin Lymphoma,

AHOD0031: A Phase III Study of Dose-Intensive Therapy for Intermediate Risk Hodgkin Lymphoma: A Report From the Children's Oncology Group

High Prevalence of Metabolic Syndrome Traits in Children with Acute Lymphoblastic Leukemia Entering Maintenance Therapy.

Population-Based Analysis of Late Cardiovascular Morbidity and Hospitalizations After Hematopoietic Cell Transplantation.

Prevalence of Metabolic Syndrome among Childhood Leukemia Survivors Treated with and without Hematopoietic Cell Transplantation

Risk Factors for Second Malignancies after Transplantation Differ between Allogeneic and Autologous Transplantation.

Is the Risk of Breast Cancer Increased after Hematopoietic Cell Transplantation?.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only